All In MedTech

FDA Clearance Tracker · P160014

COBRA PzF NanoCoated Coronary Stent System

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Feb 21, 2017 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Feb 21, 2017

Approval withdrawn

Time to decision

295 days

Received May 2, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P160014
Device name
COBRA PzF NanoCoated Coronary Stent System
Applicant location
San Antonio, TX
Received
May 2, 2016
Decided
Feb 21, 2017
Decision
Approval withdrawn
Supplements
18 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code MAF

FDA's approval statement

As written in FDA's record.

Approval for the COBRA PzF NanoCoated Coronary Stent System is indicated for improving coronary luminal diameter in patients, including patients with diabetes mellitus, with symptomatic ischemic heart disease due to do novo lesions in native coronary arteries. The COBRA PzF Stent System is intended for use in patients eligible for percutaneous transluminal coronary angioplasty (PTCA) with a reference vessel diameter of 2.5-4.0 mm and lesion length of <24 mm.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MAF. The earliest in FDA's data is P910030, decided Feb 8, 1993.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Celonova Biosciences, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.